Chelsea Therapeutics to Present at the 2013 Wedbush Life Sciences Management Access Conference
07 août 2013 07h00 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Aug. 7, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 2013 Wedbush Life Sciences Management Access Conference at 10:20...
Chelsea Therapeutics Reports Second Quarter 2013 Financial Results
06 août 2013 16h11 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the second quarter ended June 30, 2013.
"Chelsea...
Chelsea Therapeutics Announces Update to NORTHERA(TM) (Droxidopa) NDA Filing
29 juil. 2013 07h30 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., July 29, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that the U.S. Food and Drug Administration (FDA), upon further review of the...
Chelsea Therapeutics Announces FDA Acceptance of NORTHERA(TM) (droxidopa) NDA Resubmission
17 juil. 2013 09h30 HE
|
Chelsea Therapeutics
PDUFA Date Set as January 3, 2014
CHARLOTTE, N.C., July 17, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that the U.S. Food and Drug...
Chelsea Therapeutics Resubmits New Drug Application for NORTHERA(TM) (droxidopa) for the Treatment of Symptomatic NOH
09 juil. 2013 07h30 HE
|
Chelsea Therapeutics
• Submission Includes Successful 300 mg Bioequivalence Study
• Six Month Review Decision Expected Under PDUFA
CHARLOTTE, N.C., July 9, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics...
Chelsea Therapeutics Added to Russell 3000(R) and Russell 2000(R) Indexes
01 juil. 2013 07h00 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., July 1, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that it was added to the Russell 3000® and Russell 2000® Indexes when...
Chelsea Therapeutics to Present at the 38th Annual Deutsche Bank Health Care Conference
22 mai 2013 08h00 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., May 22, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 38th Annual Deutsche Bank Health Care Conference at 4:50 PM on...
Chelsea Therapeutics Reports First Quarter 2013 Financial Results
01 mai 2013 16h16 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., May 1, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the first quarter ended March 31, 2013.
"In the first...
Chelsea Therapeutics to Present at the 12th Annual Needham Healthcare Conference
24 avr. 2013 09h25 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., April 24, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present the 12th Annual Needham Healthcare Conference at 10:40 AM on...
Chelsea Therapeutics Announces Presentation of Northera(TM) (droxidopa) Study 306 Data at the American Academy of Neurology Annual Meeting
19 mars 2013 08h00 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 19, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that Dr. Stuart Isaacson, Clinical Associate Professor, Department of...